Synthesis and SAR of 2,4-diaminopyrimidines as potent c-jun N-terminal kinase inhibitors

被引：7

作者：

Song, Xinyi ^{[1
]}

He, Yuanjun ^{[1
]}

Koenig, Marcel ^{[1
]}

Shin, Youseung ^{[1
]}

Noel, Romain ^{[1
]}

Chen, Weimin ^{[1
]}

Ling, Yuan Yuan ^{[1
]}

Feurstein, Daniel ^{[1
]}

Lin, Li ^{[1
]}

Ruiz, Claudia H. ^{[1
]}

Cameron, Michael D. ^{[1
]}

Duckett, Derek R. ^{[1
]}

Kamenecka, Theodore M. ^{[1
]}

机构：

[1] Scripps Res Inst, Dept Mol Therapeut & Translat Res Inst, Jupiter, FL 33458 USA

来源：

MEDCHEMCOMM | 2012年 / 3卷 / 02期

关键词：

PROTEIN-KINASE; SIGNAL-TRANSDUCTION; ACTIVATION DOMAIN; PHOSPHORYLATION; STRESS; CARCINOMA; ATF-2; BINDS; JNK1;

D O I：

10.1039/c1md00219h

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The design and synthesis of a potent series of c-jun N-terminal kinase (JNK2) inhibitors is described. The development and optimization of the 2,4-diaminopyrimidines series was carried out from an earlier in-house kinase inhibitor program. Through the optimization of the scaffold 2, several cell potent compounds with good in vivo profiles were discovered.

引用

页码：238 / 243

页数：6

共 50 条

[21] Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development
Wang, Juan
Tai, Guixiang
TARGETED ONCOLOGY, 2016, 11 (06) : 723 - 738
[22] Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors
Schepetkin, Igor A.
Kovrizhina, Anastasia R.
Stankevich, Ksenia S.
Khlebnikov, Andrei I.
Kirpotina, Liliya N.
Quinn, Mark T.
Cook, Matthew J.
FRONTIERS IN PHARMACOLOGY, 2022, 13
[23] Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2
Nicolson, K
Freland, S
Weir, C
Delahunt, B
Flavell, RA
Bäckström, BT
INTERNATIONAL IMMUNOLOGY, 2002, 14 (08) : 849 - 856
[24] Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase
Jones, Emma V.
Dickman, Mark J.
Whitmarsh, Alan J.
BIOCHEMICAL JOURNAL, 2007, 405 (03) : 617 - 623
[25] On the effect of hippocampal c-Jun N-terminal kinase inhibition on object recognition memory
Rossato, Janine I.
Radiske, Andressa
Gonzalez, Maria Carolina
Bevilaqua, Lia R. M.
Cammarota, Martin
FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2022, 16
[26] Vincristine activates c-Jun N-terminal kinase in chronic lymphocytic leukaemia in vivo
Bates, Darcy J. P.
Lewis, Lionel D.
Eastman, Alan
Danilov, Alexey V.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (03) : 493 - 501
[27] Activation by phosphorylation and purification of human c-Jun N-terminal kinase (JNK) isoforms in milligram amounts
Thevenin, Anastasia F.
Zony, Chati L.
Bahnson, Brian J.
Colman, Roberta F.
PROTEIN EXPRESSION AND PURIFICATION, 2011, 75 (02) : 138 - 146
[28] Recent Progress in the Design, Study, and Development of c-Jun N-Terminal Kinase Inhibitors as Anticancer Agents
Messoussi, Abdellah
Feneyrolles, Clemence
Bros, Aurelie
Deroide, Arthur
Dayde-Cazals, Benedicte
Cheve, Gwenael
Van Hijfte, Nathalie
Fauvel, Benedicte
Bougrin, Khalid
Yasri, Aziz
CHEMISTRY & BIOLOGY, 2014, 21 (11): : 1433 - 1443
[29] c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer's Diseases
Hepp Rehfeldt, Stephanie Cristine
Majolo, Fernanda
Goettert, Marcia Ines
Laufer, Stefan
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 33
[30] Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases
Zhu, Yumeng
Shuai, Wen
Zhao, Min
Pan, Xiaoli
Pei, Junping
Wu, Yongya
Bu, Faqian
Wang, Aoxue
Ouyang, Liang
Wang, Guan
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (05) : 3758 - 3775

← 1 2 3 4 5 →